Curcumin cervical cancer trial pulled before start
NCT ID NCT02554344
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 14 times
Summary
This study planned to test whether curcumin, a natural compound found in turmeric, could safely help shrink or eliminate high-grade cervical precancerous lesions (CIN3) in women. It aimed to enroll women aged 21 and older with confirmed CIN3 and give them oral curcumin for 12 weeks. However, the trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.